Niall Patrick Quinn

Niall Patrick Quinn's AcademicInfluence.com Rankings

Niall Patrick Quinn

Medical

#1684

World Rank

#2050

Historical Rank

Neurology

#146

World Rank

#213

Historical Rank

medical Degrees

Niall Patrick Quinn

Philosophy

#5096

World Rank

#7820

Historical Rank

Logic

#2429

World Rank

#3419

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Niall Patrick Quinn Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Niall Patrick Quinn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Second consensus statement on the diagnosis of multiple system atrophy (2008) (2532)
Clinical diagnostic criteria for dementia associated with Parkinson's disease (2007) (2413)
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) (1996) (2382)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. (1996) (2280)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) (1996) (2138)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation (2008) (1630)
Consensus statement on the diagnosis of multiple system atrophy (1998) (1415)
What contributes to quality of life in patients with Parkinson's disease? (2000) (1108)
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. (2005) (1030)
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. (1992) (884)
Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. (1994) (742)
Multiple system atrophy: A review of 203 pathologically proven cases (1997) (741)
A common LRRK2 mutation in idiopathic Parkinson's disease (2005) (739)
Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. (2006) (487)
Quality of life in Parkinson's disease: The relative importance of the symptoms (2008) (478)
Dyskinesias following neural transplantation in Parkinson's disease (2002) (447)
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) (2004) (443)
The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. (2004) (434)
Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease (2010) (400)
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype (2001) (387)
The role of pathogenic DJ‐1 mutations in Parkinson's disease (2003) (387)
The natural history of multiple system atrophy: a prospective European cohort study (2013) (376)
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. (1986) (373)
Levodopa in the treatment of Parkinson's disease: Current controversies (2004) (370)
Fluctuations of disability in Parkinson's disease – clinical aspects (1981) (369)
Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease (1997) (360)
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? (2013) (349)
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial (2007) (349)
Parkin disease: a phenotypic study of a large case series. (2003) (332)
The syndrome of fixed dystonia: an evaluation of 103 patients. (2004) (327)
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. (2005) (324)
Blepharospasm: a review of 264 patients. (1988) (315)
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. (2000) (298)
Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants (2010) (296)
Young‐onset Parkinson's disease revisited—clinical features, natural history, and mortality (1998) (293)
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. (1999) (284)
The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. (1990) (283)
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. (1994) (272)
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges (2005) (267)
Delayed recovery of movement‐related cortical function in Parkinson's disease after striatal dopaminergic grafts (2000) (267)
Young‐ versus older‐onset Parkinson's disease: Impact of disease and psychosocial consequences (2003) (256)
Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports. (2014) (254)
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations (2001) (254)
UCHL1 is a Parkinson's disease susceptibility gene. (2004) (247)
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. (2005) (243)
Clinicopathological study of 35 cases of multiple system atrophy. (1995) (243)
Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs) (2007) (243)
Strength in Parkinson's disease: Relationshp to rate of force generation and clinical status (1996) (241)
What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? (2000) (236)
Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study (2010) (227)
Olfactory function in atypical parkinsonian syndromes (1995) (226)
Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry (2010) (212)
Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment (2005) (207)
The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease (2000) (205)
Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. (1995) (204)
PAINFUL PARKINSON'S DISEASE (1986) (201)
Red flags for multiple system atrophy (2008) (198)
Effect of electrode contact location on clinical efficacy of pallidal deep brain stimulation in primary generalised dystonia (2007) (190)
Survival of patients with pathologically proven multiple system atrophy (1997) (183)
Accuracy of clinical diagnosis of progressive supranuclear palsy (2004) (182)
Neurofilament inclusion body disease: a new proteinopathy? (2003) (180)
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. (2006) (179)
A heterozygous effect for PINK1 mutations in Parkinson's disease? (2006) (175)
Multicenter study on deep brain stimulation in Parkinson's disease: An independent assessment of reported adverse events at 4 years (2008) (175)
Natural history and syndromic associations of orthostatic tremor: A review of 41 patients (2004) (172)
Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease. (2010) (170)
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation (2010) (168)
Sexual function in patients with Parkinson's disease and their partners. (1990) (163)
Olfactory threshold in Parkinson's disease. (1987) (161)
Rate of clinical progression in Parkinson's disease. A prospective study (2007) (159)
In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy (2006) (159)
Graft‐induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio (2011) (158)
A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. (1998) (156)
The clinical approach to movement disorders (2010) (156)
Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. (1997) (154)
The natural history of tardive dystonia. A long-term follow-up study of 107 cases. (1998) (153)
How common are complications of Parkinson's disease? (2002) (148)
Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease (1987) (148)
Classification of fluctuations in patients with Parkinson's disease (1998) (147)
Cognitive performance in multiple system atrophy. (1992) (147)
The Factors that Induce or Overcome Freezing of Gait in Parkinson’s Disease (2008) (145)
Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease. (1984) (144)
Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography (1986) (144)
The performance on learning tasks of patients in the early stages of Parkinson's disease (1989) (143)
Consensus statement on the diagnosis of multiple system atrophy (1998) (142)
The treatment of severe dystonia in children and adults. (1984) (132)
COMPLICATED RESPONSE FLUCTUATIONS IN PARKINSON'S DISEASE: RESPONSE TO INTRAVENOUS INFUSION OF LEVODOPA (1982) (130)
Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson’s Patients Treated with Dopamine Grafts (2012) (127)
What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies (2015) (126)
Tau gene and Parkinson’s disease: a case–control study and meta-analysis (2004) (124)
GLUT1 gene mutations cause sporadic paroxysmal exercise‐induced dyskinesias (2009) (123)
Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? (2002) (122)
A genome-wide association study in multiple system atrophy (2016) (122)
Preservation of the substanitia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four‐year period (1986) (118)
Survival in multiple system atrophy (2008) (117)
Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease (2004) (117)
Parkin disease: a clinicopathologic entity? (2013) (116)
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy (1990) (115)
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. (2004) (114)
Deep brain stimulation effects in dystonia: Time course of electrophysiological changes in early treatment (2011) (113)
Tremor—some controversial aspects (2011) (112)
A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism (2000) (112)
Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG) (2006) (112)
A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy (2010) (106)
Oculomotor function in multiple system atrophy: Clinical and laboratory features in 30 patients (2008) (103)
Paroxysmal kinesigenic choreoathetosis: a report of 26 patients (1999) (103)
The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. (1989) (102)
Olivopontocerebellar pathology in multiple system atrophy (1996) (102)
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. (2005) (101)
Health‐related quality of life in multiple system atrophy (2006) (101)
Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. (1988) (100)
Micturition disturbance in Parkinson's disease. (1985) (99)
On the Nature of Fear of Falling in Parkinson’s Disease (2011) (98)
Arm tremor in cervical dystonia differs from essential tremor and can be classified by onset age and spread of symptoms. (2001) (98)
Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. (2019) (97)
UCHL‐1 is not a Parkinson's disease susceptibility gene (2006) (97)
Severe tongue protrusion dystonia (2006) (96)
Sweating dysfunction in Parkinson's disease (2003) (95)
Paroxysmal exercise‐induced dystonia: Eight new sporadic cases and a review of the literature (1997) (94)
"Minimal change" multiple system atrophy. (1994) (94)
“Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide (2013) (93)
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. (1998) (93)
A validation exercise on the new consensus criteria for multiple system atrophy (2009) (92)
Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. (2001) (90)
Pallidal stimulation modifies after-effects of paired associative stimulation on motor cortex excitability in primary generalised dystonia (2007) (89)
REM sleep behaviour disorder as the presenting symptom of multiple system atrophy. (1995) (88)
Sequencing ability in Parkinsonians, patients with frontal lobe lesions and patients who have undergone unilateral temporal lobectomies (1989) (87)
Dementia and Parkinson's disease--pathological and neurochemical considerations. (1986) (87)
The effect of real and virtual visual cues on walking in Parkinson’s disease (2011) (87)
Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. (1995) (87)
Huntington’s disease and other choreas (1998) (84)
Vascular parkinsonism. (2004) (84)
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP (2003) (84)
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia. (1984) (82)
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation (2015) (81)
The dystonias. (1990) (78)
Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystonia (2000) (78)
The European Multiple System Atrophy-Study Group (EMSA-SG) (2005) (78)
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs) (2009) (77)
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. (2011) (77)
Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study. (1995) (75)
The epsilon-sarcoglycan gene in myoclonic syndromes (2005) (75)
Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS‐III), and disability assessment compared with Parkinson's disease (2002) (74)
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period. (1986) (74)
The significance of ophthalmological symptoms in idiopathic blepharospasm (1988) (74)
A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study (2000) (74)
Atypical and typical cranial dystonia following dental procedures (1999) (72)
Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease (2005) (71)
Parkinson's disease is not associated with the combined α‐synuclein/apolipoprotein E susceptibility genotype (2001) (69)
Mitochondrial respiratory chain function in multiple system atrophy (1997) (69)
ADCY5 mutations are another cause of benign hereditary chorea (2015) (68)
Dopa Dose-Dependent Sexual Deviation (1983) (67)
Ramsay hunt syndrome and coeliac disease: A new association? (1986) (64)
Benign hereditary chorea—Entity or syndrome? (1999) (64)
The motor disorder of multiple system atrophy. (1993) (63)
COMPARISONS OF THERAPEUTIC EFFECTS OF LEVODOPA, LEVODOPA AND SELEGILINE, AND BROMOCRIPTINE IN PATIENTS WITH EARLY, MILD PARKINSONS-DISEASE - 3-YEAR INTERIM-REPORT (1993) (63)
Pergolide in late‐stage Parkinson disease (1982) (62)
Health‐related quality of life in patients with progressive supranuclear palsy (2003) (61)
How to diagnose multiple system atrophy (2005) (61)
The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease. (1999) (61)
Comparative responsiveness of Parkinson's disease scales to change over time (2009) (61)
The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy (2007) (60)
A critique of the second consensus criteria for multiple system atrophy (2019) (59)
A 6.4 Mb duplication of the α-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations. (2014) (58)
Prism adaptation and other tasks involving spatial abilities in patients with Parkinson's disease, patients with frontal lobe lesions and patients with unilateral temporal lobectomies (1990) (58)
Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study (2007) (58)
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy (1995) (57)
A functional polymorphism regulating dopamine β‐hydroxylase influences against Parkinson's disease (2004) (57)
Adult‐onset primary lower limb dystonia (2006) (56)
Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study. (1994) (56)
Progression of parkinsonism in multiple system atrophy (2005) (56)
Piracetam in the treatment of different types of myoclonus. (1988) (54)
Impact of Parkinson's disease on patients' adolescent and adult children. (2004) (53)
Choreic syndrome and coeliac disease: A hitherto unrecognised association (2004) (53)
Mutation analysis in patients with possible but apparently sporadic Huntington's disease (1994) (51)
Cortical myoclonus in huntington's disease (1994) (51)
H‐ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations? (2015) (51)
Antibody-Induced Botulinum Toxin Therapy Failure: Can It Be Overcome by Increased Botulinum Toxin Doses? (2002) (51)
Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis (2005) (50)
The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late‐onset cerebellar atrophy (1996) (50)
Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem– thalamic lesion: Structural and functional abnormalities studied with CT, MRI, and PET scanning (1986) (49)
Health‐related quality of life following bilateral intrastriatal transplantation in Parkinson's disease (2000) (49)
Water intoxication due to carbamazepine. (1977) (48)
Atypical movement disorders in antiphospholipid syndrome (2006) (47)
Hyposmia in pure autonomic failure (2009) (46)
Chapter 69 The clinical application of cell grafting techniques in patients with Parkinson's disease (1990) (45)
Familial dystonia and visual failure with striatal CT lucencies. (1986) (45)
Application of the International Cooperative Ataxia Scale rating in multiple system atrophy (2002) (44)
DJ-1 mutations in Parkinson's disease. (2004) (44)
Parkinson's disease: drug therapy. (1997) (44)
The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism (2004) (43)
Pallidotomy and incidental sequence learning in Parkinson's disease (2003) (43)
A Yorkshire family with adult‐onset cranio‐cervical primary torsion dystonia (2000) (43)
Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: An 18F‐dopa PET progression study (2009) (43)
Occupational therapy in multiple system atrophy: A pilot randomized controlled trial (2004) (43)
Parkinson's disease: clinical features. (1997) (43)
Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type (2003) (43)
Striatal Contribution to Cognition: Working Memory and Executive Function in Parkinson's Disease before and after Unilateral Posteroventral Pallidotomy (2002) (42)
Multiple system atrophy. (2004) (42)
Adult‐onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies (2004) (41)
Clinical features and natural history of axial predominant adult onset primary dystonia (1997) (41)
Upregulation of dopamine D2 receptors in dopaminergic drug‐naive patients with parkin gene mutations (2006) (41)
Phenotypic homogeneity of the Huntington disease–like presentation in a SCA17 family (2006) (40)
The natural history of Unverricht‐Lundborg disease: A report of eight genetically proven cases (2008) (40)
Cerebellar presentation of multiple system atrophy (1997) (40)
Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson’s disease (2004) (40)
Changes in blink reflex excitability after globus pallidus internus stimulation for dystonia (2006) (39)
Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson’s disease (2005) (39)
Abnormal interaction between vestibular and voluntary head control in patients with spasmodic torticollis. (2001) (36)
L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates (2007) (36)
Associative learning in patients with cerebellar ataxia. (1996) (36)
Stridor in multiple system atrophy (2019) (36)
Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration (1997) (36)
Anti-basal ganglia antibodies in patients with atypical dystonia and tics (2004) (35)
Difference in MSA phenotype distribution between populations: genetics or environment? (2012) (35)
Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation (2000) (34)
Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections (2006) (34)
The entity of young onset primary cervical dystonia (2007) (34)
Nonmotor symptoms in Parkin gene‐related parkinsonism (2010) (34)
Bromocriptine in Parkinson's disease: a study of cardiovascular effects. (1981) (34)
Measuring quality of life in PSP (2006) (32)
Primary lateral sclerosis mimicking atypical parkinsonism (2007) (32)
Single-dose pharmacokinetics of Madopar HBS in patients and effect of food and antacid on the absorption of Madopar HBS in volunteers. (1987) (32)
The EQ-5 D — a generic quality of life measure — is a useful instrument to measure quality of life in patients with Parkinson ’ s disease (2000) (31)
Quality of life in patients with orthostatic tremor (2003) (31)
Pisa syndrome after unilateral pallidotomy in Parkinson’s disease: an unrecognised, delayed adverse event? (2006) (30)
The α-synuclein gene in multiple system atrophy (2006) (30)
Unilateral pallidotomy for Parkinson’s disease: results after more than 1 year (1999) (29)
Beginning‐of‐dose and rebound worsening in MPTP‐treated common marmosets treated with levodopa (2002) (29)
Young‐onset multiple system atrophy: Clinical and pathological features (2018) (29)
Depression in multiple system atrophy and in idiopathic Parkinson's disease: A pilot comparative study (1996) (29)
Are patients with Parkinson's disease more likely to have periventricular hyperintensities develop? (1996) (29)
Brain dopaminergic system studied in patients with dystonia using positron emission tomography. (1988) (29)
Disorders of movement : clinical, pharmacological and physiological aspects (1989) (29)
Adult‐onset generalized dystonia due to a mutation in the neuroferritinopathy gene (2005) (28)
Soluble adhesion molecules in Gilles de la Tourette's syndrome (2005) (28)
Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy (2001) (28)
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders. (1988) (28)
The antiparkinsonian actions and pharmacokinetics of transdermal (+)‐4‐Propyl‐9‐hydroxynaphthoxazine (+ PHNO): Preliminary results (1989) (27)
Neurological complications associated with parenteral treatment: central pontine myelinolysis and Wernicke's encephalopathy. (1986) (27)
Sequence analysis of tau in familial and sporadic progressive supranuclear palsy (2002) (26)
Development of a measure of the impact of chronic parental illness on adolescent and adult children. The parental illness impact scale (Parkinson's disease). (2004) (25)
Spontaneously changing muscular activation pattern in patients with cervical dystonia (2001) (25)
Lisuride in dystonia (1985) (25)
In vivo assessment of brain monoamine systems in parkin gene carriers: A PET study (2010) (25)
The clinical application of cell grafting techniques in patients with Parkinson's disease. (1990) (24)
Firing patterns of pallidal cells in Parkinsonian patients correlate with their pre‐pallidotomy clinical scores (2000) (24)
Multiple sclerosis presenting as adult onset dystonia (1988) (24)
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease (2003) (24)
LITHIUM FOR PAINFUL DYSTONIA IN PARKINSON'S DISEASE (1986) (23)
Levodopa reversible loss of the Piper frequency oscillation component in Parkinson's disease (2001) (23)
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease. (1987) (23)
Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting (2018) (22)
Blepharospasm and limb dystonia caused by Mohr‐Tranebjaerg syndrome with a novel splice‐site mutation in the deafness/dystonia peptide gene (2007) (22)
Are Trials of Intravascular Infusions of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy Currently Justified, and Are They Effective? (2008) (22)
Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy (2009) (22)
Unusual familial presentation of epsilon‐sarcoglycan gene mutation with falls and writer's cramp (2008) (22)
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin‐linked Parkinson's disease (2006) (22)
Hippocampal α-synuclein pathology correlates with memory impairment in multiple system atrophy. (2020) (22)
Open study of Madopar HBS, a new formulation of levodopa with benserazide, in 13 patients with Parkinson's disease and 'on-off' fluctuations. (1987) (22)
Idiopathic blepharospasm does not lead to a parkinsonian syndrome: results of a questionnaire-based follow-up study (1999) (22)
CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy (1995) (21)
Stridor in multiple system atrophy Consensus statement on diagnosis, prognosis, and treatment (2019) (21)
Contact with a nurse practitioner: a short-term evaluation study in Parkinson's disease and dystonia. (1994) (21)
The clinical use of apomorphine in Parkinson's disease (1992) (21)
Prospective study of swallowing function in patients with cervical dystonia undergoing selective peripheral denervation (2001) (21)
Samuel Alexander Kinnier Wilson. Wilson's disease, Queen Square and neurology. (2013) (20)
The syndrome of (predominantly cervical) dystonia and cerebellar ataxia: new cases indicate a distinct but heterogeneous entity (2006) (20)
Markedly asymmetric presentation in multiple system atrophy. (2013) (20)
Unilateral abolition of extrapyramidal rigidity after ipsilateral cerebellar, infarction (1987) (20)
Psychotic and Depressive Symptoms in Parkinson's Disease a Study of the Growth Hormone Response to Apomorphine (1995) (19)
Parkinsonism. Multiple system atrophy. (1997) (19)
Vascular parkinsonism (2004) (19)
Contractures of the extremities in parkinsonian subjects: a report of three cases with a possible association with bromocriptine treatment. (1988) (19)
Absence of antibodies to cardiolipin in patients with Huntington's chorea, Sydenhams chorea and acute rheumatic fever. (1988) (18)
Genetic diagnosis in Lafora disease (2007) (18)
UCHL‐1 gene in multiple system atrophy: A haplotype tagging approach (2005) (18)
Familial Lafora body disease of late onset: report of four cases in one family and a review of the literature (1996) (18)
Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy. (1995) (18)
Parkinsonism and dystonia, pseudo-parkinsonism and pseudodystonia. (1993) (18)
Parkinson's Disease and other Movement Disorders (2016) (17)
[Multiple system atrophy with Lewy bodies]. (1995) (17)
NR4A2 genetic variation in sporadic Parkinson's disease: A genewide approach (2006) (17)
Hormone replacement therapy induced chorea. (1991) (17)
Soft signs in movement disorders: friends or foes? (2018) (16)
Cortical Reflex Myoclonus Responds to Intravenous Lisuride (1983) (16)
[Consensus on the diagnosis of multi-system atrophy]. (1999) (16)
Continuous subcutaneous lisuride infusions in Parkinson's disease. (1988) (16)
Reckless generosity in Parkinson's disease (2010) (16)
The Shy-Drager syndrome. What did Shy and Drager really describe? (1995) (15)
Antineuronal antibodies in Parkinson's disease (2008) (15)
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study. (2018) (15)
Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers) (2015) (15)
Status dystonicus: the syndrome and its management. (1998) (15)
Antiparkinsonian activity of single oral dose of PHNO (1987) (14)
The Unified Multiple System Atrophy Rating Scale: Intrarater reliability (2012) (14)
Progressive supranuclear palsy‐like phenotype associated with bilateral hypoxic–ischemic striopallidal lesions (2005) (13)
Functional neurosurgery for Parkinson's disease (1998) (13)
Coincidence of Wilson's disease with other movement disorders in the same family. (1986) (13)
Parkinson's disease: the spectrum of disabilities. (1992) (13)
Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy (2021) (12)
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment. (2021) (12)
A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease.(vol 55, 443, 2004) (2004) (12)
Characteristic constant groaning in late stage progressive supranuclear palsy: a case report. (2011) (11)
Abnormal circadian rhythms of plasma melatonin and body temperature in the delayed sleep phase syndrome (11)
Lisuride in the treatment of myoclonus. (1986) (11)
Polymyography Combined with Time-Locked Video Recording (Video EMG) for Presurgical Assessment of Patients with Cervical Dystonia (2001) (11)
Nasogastric and intravenous infusions of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's disease. (1990) (11)
OSH Parkinson's Disease and Other Movement Disorders (2008) (10)
A Case Against Early Levodopa Treatment of Parkinson's Disease (1994) (10)
A common mutation in idiopathic Parkinson's disease (2005) (10)
What contributes to quality of life in Parkinson’s disease: a re-evaluation (2020) (10)
Parkin‐related disease clinically diagnosed as a pallido‐pyramidal syndrome (2009) (9)
Myoclonus in spinal dysraphism (2003) (9)
Tiapride in 12 Huntington's disease patients. (1985) (8)
Juvenile parkinsonism caused by chronic meningoencephalitis: a clinicopathological study. (1993) (8)
A Clinicopathologic Entity (2017) (8)
Charles David Marsden. 15 April 1938 — 29 September 1998 (2012) (8)
Insulin-induced hypoglycaemia does not abolish chorea. (1982) (7)
Falls and injuries in Progressive Supranuclear Palsy (PSP) (2002) (7)
Longitudinal effects of deep brain stimulation in the globus pallidus on intracortical GABAergic inhibition and LTP-like plasticity in dystonia (2009) (7)
Neurofilament inclusion body disease (2003) (7)
Young onset limb spasticity with PSP-like brain and spinal cord NFT-tau pathology (2005) (7)
Paraneoplastic Cerebellar Ataxia due to Burnt-Out Testicular Germ Cell Tumour? (2007) (7)
Spinal rigidity following acute myelitis (1997) (7)
ESSENTIAL TREMOR. AUTHOR'S REPLY (1992) (6)
The genetic basis and phenotypic variability in early onset parkinsonism (2002) (6)
Paroxysmal dyskinesia with interictal myoclonus and dystonia: a report of two cases. (2008) (6)
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)]. (1981) (6)
Clinical Study of 668 Indian Subjects with Juvenile, Young and Early Onset Parkinson's Disease. (2021) (6)
Progressive supranuclear palsy (2003) (5)
Parkinson's disease and other movement disorders : Oxford specialist handbooks (2008) (5)
The dancing larynx—a variant of palatal tremor? (1999) (5)
Multiple system atrophy: the nature of the beast revisited (2019) (5)
Familial camptocormia: from dystonia to myopathy (2011) (5)
MAGNETIC RESONANCE IMAGING TO DETECT DEEP BASAL GANGLIA LESIONS IN HEMIDYSTONIA THAT ARE MISSED BY COMPUTERISED TOMOGRAPHY (1985) (5)
Does rest tremor exclude the diagnosis of adult-onset primary dystonia? (2013) (5)
Pergolide in the treatment of Parkinson's disease. (1984) (5)
Parkinson's disease dyskinesias (1994) (5)
Reply from the Authors (1997) (4)
Ataxia without telangiectasia revisited: Update on genetic findings in two brothers with an ataxia‐telangiectasia‐like disorder (2001) (4)
Frontotemporal lobar degeneration‐TDP with ‘multiple system atrophy phenocopy syndrome’ (2017) (4)
Transderm-induced psychosis in Parkinson's disease. (2000) (4)
PARKIN DISEASE–A CLINICOPATHOLOGICAL ENTITY? (2013) (3)
10 – The integrity of the dopaminergic system in patients with multiple system atrophy and pure autonomic failure studied with PET (1990) (3)
Lisuride and pergolide in Parkinson's disease. (1983) (3)
[Pseudotransitory ischemic attacks as the initial symptom of multiple system atrophy]. (1995) (3)
Classics in Neurology (1983) (3)
Selegiline and nigral neurons (1992) (3)
What are the non-motor symptoms of Parkinson’s disease? (2009) (3)
A strategy for measuring the therapeutic properties of new antiparkinsonian drugs, such as +PHNO, in patients with on-off fluctuations. (1989) (3)
Re: Yianni et al., Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit (2004) (3)
Aid in writer's cramp (1989) (3)
Erratum: Levodopa in the treatment of Parkinson's disease: Current controversies (Movement Disorders) (2004)) (2005) (3)
1.278 Adult onset dystonic tremor as differential diagnosis for Parkinson's disease: Detailed clinical description of 20 patients emphasizing non-motor symptoms including olfactory function (2007) (2)
The antiparkinsonian activity of CQA 206-291, a new D2 dopamine receptor agonist. (1989) (2)
ON-OFF SYNDROME IN PARKINSON'S DISEASE AND INTRAVENOUS LEVODOPA (1982) (2)
Selective peripheral denervation with posterior primary ramisectomy is useful for botulinum toxin resistant patients with cervical dystonia: Results of a prospective study (1999) (2)
Anti-Parkinsonian Drugs Today (1984) (2)
a-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Aoife P. KielyYasmine T. AsiEleanna KaraPatricia LimousinHelen Ling • Patrick LewisChristos ProukakisNiall QuinnAndrew J. LeesJohn Hardy • (2013) (2)
15th International World Federation of Neurology Workshop on Huntington's Disease, 31 August-3 September 1993, Boston, Massachusetts, USA. (1993) (2)
Cleopatra-PD: Clinical efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease (2007) (2)
[Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm]. (1989) (2)
Soluble adhesion molecules in Gilles de la Tourette's syndrome (vol 234, pg 79, 2005) (2006) (2)
Essential tremor (1992) (2)
CLASSIFICATION OF FLUCTUATION IN PATIENTS WITH PARKINSON'S DISEASE (1998) (2)
Prevalence of abnormal movement disorders associated with neuroleptics. (1992) (2)
Severe tongue protrusion dystonia: clinical syndromes and their management (2006) (2)
Synucleinopathy with a G51D a-synuclein mutation: a neuropathological and genetic study (2013) (2)
Adult-onset primary lower limb dystonia: Clinical description of a rare entity (2005) (2)
Erratum: A functional polymorphism regulating dopamine β-hydroxylase influences against Parkinson's disease (Annals of Neurology (March 2004) 55 (443-446) DOI: 10.1002/ana.20235 (2004) (2)
Safety and tolerability of growth-hormone therapy in multiple system atrophy (2007) (2)
Comprar Parkinson's Disease And Other Movement Disorders (Oxford Specialist Handbooks In Neurology) 2nd Ed. | Mark Edwards | 9780198705062 | OXFORD (2016) (2)
Contents Vol. 45, 2001 (2001) (2)
Olfactory threshold inParkinson's disease (1987) (1)
Adult onset dystonia can cause tremulous pseudoparkinsoniasm and is one cause of SWEDDs: Clinical description of 30 cases (2008) (1)
Diagnosing Premotor Multiple System Atrophy (2022) (1)
Factors contributing to caregiver burden and carer quality of life in Parkinson's disease (2004) (1)
Double blind trial of dogmatil in Huntington chorea and tardive dyskinesia (1985) (1)
Functional (Psychogenic) Movement Disorders (2020) (1)
1.022 Adult onset dystonic tremor as differential diagnosis for Parkinson's disease: Detailed clinical description of 20 patients emphasizing non-motor symptoms including olfactory function (2007) (1)
The cause of blepharospasm is unknown in most cases. (1990) (1)
Erratum: Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements. An H2 15O PET study (Brain. Journal of Neurology (1997) 120, 8 (1301-1313)) (1998) (1)
Paroxysmal movement disorders (2008) (1)
Evoked potentials in multiple system atrophy (1990) (1)
Dementia with Lewy Bodies: Résumé of treatment workshop sessions (1996) (1)
Brain monoaminergic innervation in Parkin patients: A PET study (2006) (1)
CAMPTOCORMIA: WHAT IS THE CAUSE? (2012) (0)
Marios Politis Parkinson ' s Patients Treated with Dopamine Grafts Serotonin Neuron Loss and Nonmotor Symptoms Continue in (2012) (0)
Parkinson’s Disease Never Presents With Freezing: Except When It Does! (2012) (0)
The spectrum of pathological involvement of multiple system atrophy (MSA): clinicopathological correlations (2005) (0)
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation (2015) (0)
Novel parkin mutations in early-onset parkinsonism (2002) (0)
Startle and stiff-person syndromes (2016) (0)
Book reviews (2004) (0)
A new family with paroxysmal exercise-induced dystonia and associated migraine (1999) (0)
Movement disorders and sleep (2008) (0)
A patient with PSP-like brain and spinal cord NFT-tau pathology presenting as young onset spastic paraplegia (2004) (0)
Parental Illness Impact Scale (Parkinson's Disease) (2014) (0)
Glucose transporter 1 gene mutations cause sporadic PED (2009) (0)
Longitudinal effects of pallidal stimulation on motor cortex function in dystonia (2007) (0)
ENS News (1999) (0)
Adult-Onset Primary Limb Dystonia: Clinical Description of a Rare Entity (2004) (0)
Abstracts of the 6th international multiple system atrophy congress (2018) (0)
Clinicopathological features of patients with multiple system atrophy with a family history of Parkinson's disease (2006) (0)
Whipple's disease diagnosed by CT (1983) (0)
Bromocriptine inParkinson's disease: astudy ofcardiovascular effects (1981) (0)
Negative correlation of glucose metabolism and microglial activation in multiple system atrophy in the lentiform nucleus – a PET study (2005) (0)
Primary lateral sclerosis mimicking atypical parkinsonian syndrome: A challenging early diagnosis (2006) (0)
Correlation of microglial activation and FDG-metabolism in patients with dementia with Lewy bodies - a PET study. (2008) (0)
The effect of pallidal stimulation on motor cortex plasticity in primary generalised dystonia (2006) (0)
PS-25-6 Muscle relaxation relates to clinical impairment in Parkinson's disease (1995) (0)
Essential tremor. (1992) (0)
External cueing and gait in Parkinson's disease: A controlled evaluation (2009) (0)
Very long-term clinical outcome of fetal cell transplantation for Parkinson's disease (2014) (0)
Appendix 1 Unified Parkinson's Disease Rating Scale (2008) (0)
Cortical evoked potentials from stimulation of globus pallidus in patients with primary generalised dystonia (2006) (0)
Long-term safety and efficacy of transdermal rotigotine in advanced Parkinson's disease (2008) (0)
Diagnosis and treatment of Parkinson’s disease: Author’s reply (1995) (0)
Clinical improvement following bilateral globus pallidus interna deep brain stimulation for generalised dystonia (2005) (0)
Relevance of PSP and MSA to clinical practice (2000) (0)
Oral presentations (2014) (0)
Paroxysmal dyskinesias and seizures associated with hemiplegic migraine: A report of three cases (2005) (0)
114th Meeting of the British Neuropathological Society Institute of Child Health, London  Symposium: ”Advances in Motor Neuron Diseases” 13th March 2013 (2013) (0)
The usefulness of SPECT DAT scans in differentiating dystonic rest tremor from Parkinson's disease: Some illustrative cases (2005) (0)
145 Pre-motor phase in autopsy-confirmed multiple system atrophy (2019) (0)
Parkinsonism Carers Quality-of-Life Instrument (2017) (0)
Exome sequencing in familial multiple system atrophy (2012) (0)
Time-course, predictors, and regional distribution of improvement in primary generalised dystonia following pallidal deep brain stimulation (2005) (0)
Clinical features and natural history of adult-onset predominantly axial dystonia (1997) (0)
Status Dystonicus - a report of 11 cases (1997) (0)
Reply (1995) (0)
Measuring quality of life in multiple system atrophy (2011) (0)
A novel 5'UTR mutation of Nurr1 reduces Nurr1 expression in Parkinson's disease brain in vivo (2006) (0)
Brain dopamine metabolism inpatients with Parkinson's disease measured withpositron emission (2011) (0)
The accuracy of clinical diagnosis of multiple system atrophy: an application with gray cases and true negative cases (2004) (0)
Domperidone. (1985) (0)
Subject Index Vol. 45, 2001 (2001) (0)
disease and their partners . Sexual function in patients with Parkinson ' s (0)
Appendix 3 Botulinum toxin injections: important information regarding dose conversion (2008) (0)
Comparison of depression, anxiety and quality of life in PSP and MSA (2009) (0)
Neurophysiological characterisation of myoclonus dystonia (2006) (0)
Other atypical parkinsonian disorders and their differentiation from dementia with Lewy bodies (2006) (0)
Anatomy and function of the basal ganglia (2008) (0)
PATH54 Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study (2010) (0)
Dopa‐responsive Dystonia (1991) (0)
The role of mendelian PD genes in non-mendelian PD: A haplotype tagging approach (2004) (0)
MULTIPLE SYSTEM ATROPHY : SPORADC OR FAMILIAL ? (1993) (0)
Incidence of and risk factors for hallucinations and delusions in patients with probable AD - Reply (2000) (0)
Common movement disorders (1992) (0)
Nigrostriatal dysfunction in parkin linked parkinsonism and asymptomatic heterozygous carriers: A progressive study with 18-dopa pet (2008) (0)
Reply: Rate of progression determines the clinical outcome after neural transplantation in Parkinson's disease (2006) (0)
Functional neural transplantation (advances in neuroscience, volume 2) Editors: Dunnett and Björklund. Published 1994 by Raven Press. ISBN 0 7817 0068 X, 603 pp. $183.00 (1996) (0)
Wilson's disease (major problems in neurology 30) by Tjaard Hoogenraad, 1996, 210 pp. Saunders, ISBN 0-7020-1842-2, £45 (1997) (0)
Appendix 2 DSM-IV-TR criteria for diagnosis of attention deficit-hyperactivity disorder (2008) (0)
Adult onset dystonic tremor with similarities to Parkinsonian tremor may be one cause of SWEDDS (2006) (0)
Drug-induced movement disorders (2008) (0)
The most cited Parkinson's disease researchers - a personal perspective. (2011) (0)
AbstractThe role of urethral sphincter electromyography in the differential diagnosis of parkinsonism (1989) (0)
The pathological basis of disproportionate antecollis in multiple system atrophy (2005) (0)
Subject Index Vol. 27, Suppl 1, 1987 (1987) (0)
Myoclonus dystonia due to e-sarcoglycane gene mutation presenting with falls (2006) (0)
The PSP QoL (PSP-QoL): A validated, patient-based outcome measure for progressive supranuclear palsy (2005) (0)
sP1.076 Fear of falling in Parkinson's disease (2008) (0)
Dysarthria in multiple system atrophy (1995) (0)
Progressive Supranuclear Palsy Quality of Life Scale (2020) (0)
0854 Camptocormia: what is the cause? (2012) (0)
Impact of parental illness on adolescent and adult children of patients with Parkinson’s disease (2002) (0)
Handbook of Dystonia (1996) (0)
A clinicopathological study of parkin-linked parkinsonism - A study of 5 cases and comparison with Parkinson's disease (2012) (0)
Olivopontocerebellar atrophy - Reply (1995) (0)
The Year in Neurology 2001 (2003) (0)
A Sporadic Case of the Myoclonic Form of Dentato-Rubro-Pallidoluysian Atrophy (DRPLA) in a Caucasian (1987) (0)
Insulin-induced hypoglycaemia does not abolish chorea. (1982) (0)
A double blind trial ofsulpiride inHuntington' s disease andtardive dyskinesia (1984) (0)
Author's reply (1995) (0)
The nature of failing in progressive supranuclear palsy (2004) (0)
Eye movements in multiple system atrophy (MSA) (2005) (0)
Patients with adult onset dystonic tremor and scans without evidence of dopaminergic deficit (SWEDDs) resembiling tremulous Parkinson's Disease: A comparative analysis of 21 cases (2008) (0)
Reply to: Young‐ onset multiple system atrophy (2018) (0)
Movement disorder in Whipple's disease (2001) (0)
Approach to patients with movement disorders (2008) (0)
Lewy bodies in surviving transplanted neurons indicate host-to-graft propagation of Parkinson's disease pathology (2009) (0)
The syndrome of dystonia and cerebellar ataxia: Cortical excitability and pathophysiological implications (2007) (0)
Politis Patients with Neural Transplants Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson ' s (2011) (0)
Measuring quality of life in progressive supranuclear palsy: The PSP-QoL (2011) (0)
Hallervorden-Spatz syndrome: unusual presentation and MRS study (2001) (0)
Clinical and neuropathological features of synucleinopathy associated with G51D SNCA mutation (2013) (0)
Preface – Special issue: Multiple system atrophy (2005) (0)
How do G51D SNCA mutation cases compare clinically and neuropathologically to SNCA duplication and H50Q SNCA mutation (2014) (0)
Movement disorders and ataxia (2008) (0)
Other dyskinetic syndromes (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Niall Patrick Quinn?

Niall Patrick Quinn is affiliated with the following schools:

University College London

Niall Patrick Quinn's Academic­Influence.com Rankings

Why Is Niall Patrick Quinn Influential?

Niall Patrick Quinn's Published Works

Published Works

What Schools Are Affiliated With Niall Patrick Quinn?

Niall Patrick Quinn's AcademicInfluence.com Rankings